These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1019225)

  • 21. Hemodynamic and metabolic effects of beta-adrenergic blockade in exercising dogs.
    Cronin RF
    J Appl Physiol; 1967 Feb; 22(2):211-6. PubMed ID: 6017885
    [No Abstract]   [Full Text] [Related]  

  • 22. The cardiovascular actions of ellipticine.
    Herman E; Vick J; Burka B
    Toxicol Appl Pharmacol; 1971 Mar; 18(3):743-51. PubMed ID: 4398230
    [No Abstract]   [Full Text] [Related]  

  • 23. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of bea-adrenergic blockade on the cardiopulmonary response to ketamine.
    Traber DL; Wilson RD; Priano LL
    Anesth Analg; 1970; 49(4):604-13. PubMed ID: 4397093
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Comparison of some haemodynamic changes between central and intravenous administration of (plus or minus)-propranolol in anaesthetized dogs.
    Carter JK; Mitchell HW; Poyser RH
    Br J Pharmacol; 1974 May; 51(1):146P-147P. PubMed ID: 4441787
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic and coronary hemodynamic effects of vasopressin.
    Corliss RJ; McKenna DH; Sialer S; O'Brien GS; Rowe GG
    Am J Med Sci; 1968 Nov; 256(5):293-9. PubMed ID: 5697613
    [No Abstract]   [Full Text] [Related]  

  • 27. The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).
    Osborne MW; Wenger JJ; Zanko MT
    J Pharmacol Exp Ther; 1977 Jan; 200(1):195-206. PubMed ID: 833757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.
    Ram N; Bauer EW; Hesse UC; Heilman RD
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):118-25. PubMed ID: 921395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-dimethylisopropyl propranolol. Effects on myocardial oxygen demands.
    Olson EG; Goodyer AV; Langou RA; Cohen LS; Wolfson S
    Circulation; 1976 Mar; 53(3):501-5. PubMed ID: 1248083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cardiorespiratory effects of intravenous isoprenaline in mechanically ventilated dogs.
    Finlay WE; Wightman AE; Sykes MK
    Br J Anaesth; 1970 Dec; 42(12):1042-50. PubMed ID: 5504444
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular activity of a deproteinized blood extract.
    Chanh PH; Chanh AP; Basile JP; Navarro C; Nguyen VT
    Arzneimittelforschung; 1980; 30(11):1874-7. PubMed ID: 7192996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of beta sympathetic blockade on the initial hemodynamic response to exercise.
    Smulyan H; Eich RH
    J Lab Clin Med; 1968 Mar; 71(3):378-89. PubMed ID: 4868950
    [No Abstract]   [Full Text] [Related]  

  • 34. [The influence of ethrane on the haemodynamics and the oxygen supply of the myocardium in comparison to halothane (author's transl)].
    Tarnow J; Gethmann JW; Hess W; Patschke D; Weymar A; Brückner JB
    Anaesthesist; 1974 Jul; 23(7):281-90. PubMed ID: 4458498
    [No Abstract]   [Full Text] [Related]  

  • 35. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
    Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
    Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and respiratory effects of dopamine on septic shock in the monkey.
    Guenter CA; Hinshaw LB
    Am J Physiol; 1970 Aug; 219(2):335-9. PubMed ID: 4988558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiovascular effects of elliptinium. The mechanism of action].
    Eschalier A; Lavarenne J; Dureng G; Rodriguez M; Tounissou P
    J Pharmacol; 1984; 15(3):301-8. PubMed ID: 6492819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac adrenergic activity in experimental heart failure assessed with beta receptor blockade.
    Vogel JH; Chidsey CA
    Am J Cardiol; 1969 Aug; 24(2):198-208. PubMed ID: 4240507
    [No Abstract]   [Full Text] [Related]  

  • 39. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
    Takeda K; Iizuka H; Imai S
    Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.